chr2-27445374-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000260570.8(IFT172):c.4990C>T(p.Arg1664Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00108 in 1,612,924 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1664Q) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000260570.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFT172 | NM_015662.3 | c.4990C>T | p.Arg1664Trp | missense_variant | 46/48 | ENST00000260570.8 | NP_056477.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFT172 | ENST00000260570.8 | c.4990C>T | p.Arg1664Trp | missense_variant | 46/48 | 1 | NM_015662.3 | ENSP00000260570 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000526 AC: 80AN: 151994Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00236 AC: 586AN: 248406Hom.: 11 AF XY: 0.00320 AC XY: 430AN XY: 134488
GnomAD4 exome AF: 0.00114 AC: 1670AN: 1460812Hom.: 36 Cov.: 32 AF XY: 0.00166 AC XY: 1204AN XY: 726618
GnomAD4 genome AF: 0.000513 AC: 78AN: 152112Hom.: 0 Cov.: 32 AF XY: 0.000753 AC XY: 56AN XY: 74352
ClinVar
Submissions by phenotype
Short-rib thoracic dysplasia 10 with or without polydactyly;C4225342:Retinitis pigmentosa 71 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 09, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at